# Chinese Herbal Medicine in Acute INtracerebral Haemorrhage (CHAIN) Trial

Study · id `cardio:ct-nct05066620` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05066620](<https://clinicaltrials.gov/study/NCT05066620>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05066620

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1504 participants.

## Technical summary

Registry record NCT05066620. Randomized; quadruple masking; primary purpose treatment. Start 2021-10 (anticipated); primary completion 2024-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1504 participants (planned count; ClinicalTrials.gov record NCT05066620, source copy `cardio:ctgov-nct05066620-2021-10-04`, retrieved 2026-10-26)
- Planned start: 2021-10 (anticipated) (ClinicalTrials.gov record NCT05066620, source copy `cardio:ctgov-nct05066620-2021-10-04`, retrieved 2026-10-26)
- Primary completion: 2024-12 (anticipated) (ClinicalTrials.gov record NCT05066620, source copy `cardio:ctgov-nct05066620-2021-10-04`, retrieved 2026-10-26)
- Completion: 2025-01 (anticipated) (ClinicalTrials.gov record NCT05066620, source copy `cardio:ctgov-nct05066620-2021-10-04`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05066620, source copy `cardio:ctgov-nct05066620-2021-10-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05066620-2021-10-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Chinese Herbal Medicine in Acute INtracerebral Haemorrhage (CHAIN) Trial
- Condition: Intracerebral Hemorrhage
- Intervention (Drug): Chinese herbal medicine FYTF-919
- Lead sponsor: Guangzhou University of Traditional Chinese Medicine
- Lead sponsor class: OTHER
- Collaborator: The George Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Guangzhou University of Traditional Chinese Medicine (`cardio:org-guangzhou-university-of-traditional-chinese-medicine`)
- Registry lists this organization as a collaborator: The George Institute for Global Health (`core:george-institute`)

## Provenance

Content hash: f80310e6847177d08d75ad15548144022e71200b0759a1d36050d31e4369f1ae
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
